Primary |
Chronic Obstructive Pulmonary Disease |
47.4% |
Asthma |
17.1% |
Emphysema |
7.9% |
Dyspnoea |
5.3% |
Hypersensitivity |
2.6% |
Migraine |
2.6% |
Anxiety |
2.0% |
Bronchiectasis |
2.0% |
Respiratory Disorder |
2.0% |
Blood Pressure Increased |
1.3% |
Fibromyalgia |
1.3% |
Hypertension |
1.3% |
Nausea |
1.3% |
Osteoarthritis |
1.3% |
Pain |
1.3% |
Arthritis |
0.7% |
Blood Cholesterol |
0.7% |
Blood Cholesterol Increased |
0.7% |
Bronchitis |
0.7% |
Bronchitis Chronic |
0.7% |
|
Dyspnoea |
22.2% |
Cough |
11.1% |
Tremor |
9.5% |
Dizziness |
6.3% |
Pneumonia |
4.8% |
Somnolence |
4.8% |
Alopecia |
3.2% |
Candidiasis |
3.2% |
Chronic Obstructive Pulmonary Disease |
3.2% |
Drug Effect Decreased |
3.2% |
Dry Mouth |
3.2% |
Fatigue |
3.2% |
Headache |
3.2% |
Heart Rate Irregular |
3.2% |
Insomnia |
3.2% |
Muscle Spasms |
3.2% |
Rash |
3.2% |
Wheezing |
3.2% |
Abdominal Discomfort |
1.6% |
Abdominal Pain |
1.6% |
|
Secondary |
Chronic Obstructive Pulmonary Disease |
30.6% |
Asthma |
20.7% |
Emphysema |
13.5% |
Osteoarthritis |
6.3% |
Osteoporosis |
6.3% |
Pain |
6.3% |
Dyspnoea |
2.7% |
Hypersensitivity |
2.7% |
Migraine |
2.7% |
Anxiety |
1.8% |
Bronchitis |
1.8% |
Bronchitis Chronic |
1.8% |
Respiratory Disorder |
1.8% |
Blood Pressure Increased |
0.9% |
|
Dizziness |
18.9% |
Dyspnoea |
10.8% |
Tremor |
10.8% |
Somnolence |
8.1% |
Fatigue |
5.4% |
Night Sweats |
5.4% |
Wheezing |
5.4% |
Aphthous Stomatitis |
2.7% |
Chest Pain |
2.7% |
Chronic Obstructive Pulmonary Disease |
2.7% |
Cough |
2.7% |
Dementia Alzheimer's Type |
2.7% |
Drug Ineffective |
2.7% |
Dysphonia |
2.7% |
Dysuria |
2.7% |
Nausea |
2.7% |
Nervousness |
2.7% |
Off Label Use |
2.7% |
Pulmonary Congestion |
2.7% |
Rash |
2.7% |
|
Concomitant |
Drug Use For Unknown Indication |
22.9% |
Chronic Obstructive Pulmonary Disease |
14.8% |
Product Used For Unknown Indication |
11.8% |
Asthma |
10.3% |
Cardiac Disorder |
6.1% |
Hypertension |
5.4% |
Emphysema |
3.7% |
Dyspnoea |
2.8% |
Prophylaxis |
2.6% |
Pulmonary Arterial Hypertension |
2.6% |
Hypersensitivity |
2.2% |
Osteoporosis |
2.0% |
Cardiac Failure Congestive |
1.8% |
Depression |
1.8% |
Gastrooesophageal Reflux Disease |
1.8% |
Lung Disorder |
1.7% |
Blood Cholesterol Increased |
1.5% |
Muscle Spasms |
1.5% |
Rheumatoid Arthritis |
1.5% |
Angina Pectoris |
1.3% |
|
Pneumonia |
16.1% |
Dyspnoea |
8.9% |
Drug Ineffective |
5.4% |
Fatigue |
5.4% |
Malaise |
5.4% |
Multiple Sclerosis Relapse |
5.4% |
Unevaluable Event |
5.4% |
Vomiting |
5.4% |
Anticonvulsant Drug Level Increased |
3.6% |
Back Pain |
3.6% |
Chronic Obstructive Pulmonary Disease |
3.6% |
Fluid Retention |
3.6% |
Gait Disturbance |
3.6% |
Nasopharyngitis |
3.6% |
Oedema Peripheral |
3.6% |
Off Label Use |
3.6% |
Palpitations |
3.6% |
Product Quality Issue |
3.6% |
Renal Cancer |
3.6% |
Senile Dementia |
3.6% |
|